Related Experiment Video

Updated: May 31, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells

Alfiya Safina1, Paula Sotomayor, Michelle Limoge

  • 1Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

Molecular Cancer Research : MCR
|June 25, 2011
PubMed

Insights

Transforming growth factor-beta-activated protein kinase 1 (TAK1) signaling in breast cancer cells drives bone destruction during metastasis. Targeting the TAK1-TAB2 axis may offer a novel therapeutic strategy for bone metastases.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Advanced breast cancers often metastasize to bone, leading to significant bone destruction.
  • The precise molecular mechanisms driving this bone metastasis and destruction remain incompletely understood.

Purpose of the Study:

  • To investigate the role of TGF-β-activated protein kinase 1 (TAK1) signaling in tumor cells in promoting bone destruction by metastatic breast cancer.
  • To identify key signaling pathways and factors involved in breast cancer bone metastasis.

Main Methods:

  • Utilized dominant-negative TAK1 (dn-TAK1) and small interfering RNA (siRNA) to suppress TAK1 signaling in MDA-MB-231 breast cancer cells.
  • Employed an intracardiac injection model to assess bone colonization and osteolysis.
  • Analyzed the expression of prometastatic factors including matrix metalloproteinase (MMP) 9, COX2, parathyroid hormone-related protein (PTHrP), and interleukin 8 (IL-8).

Main Results:

  • Suppression of TAK1 signaling impaired breast cancer cell bone colonization and reduced bone osteolysis.
  • Inhibition of TAK1 blocked the expression of MMP-9, COX2, PTHrP, and IL-8.
  • The TAK1-TAB2-TAB3 signaling axis was identified as critical for mediating proinvasive and osteolytic factors in bone metastasis, with elevated TAB2 and TAB3 expression in carcinoma cells.

Conclusions:

  • TAK1 signaling within tumor cells is a key driver of bone destruction in metastatic breast cancer.
  • The TAK1-TAB2 signaling axis represents a potential therapeutic target for treating bone metastasis in breast cancer.

More Related Videos

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...